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Abstract Aromatic amines have been shown to cause
bladder cancer. However, epithelial cells of the urinary blad-
der, cells of origin of bladder cancer, may be exposed to
numerous substances besides aromatic amines. In the present
study, we analysed possible interactions between the aro-
matic amines 4-aminobiphenyl (4-ABP) as well as 2-naph-
thylamine (2-NA) and the polycyclic aromatic hydrocarbon
benzo[a]pyrene (B[a]P). For this purpose we incubated pri-
mary porcine urinary bladder epithelial cells (PUBEC) with
concentrations of 1 to 50 M 4-ABP with and without co-
exposure to B[a]P. As expected B[a]P increased mRNA
expression of cytochrome P450 1A1 (CYP1A1), whereas
4-ABP had no eVect. However, when co-exposed 4-ABP
enhanced the induction of CYP1A1 by B[a]P. This result
was conWrmed by Western blot analysis of CYP1A1 protein
expression. A similar eVect as for CYP1A1 was also
observed for cyclooxygenase-2 (COX-2) and UDP-glucuron-
osyltransferase 1 (UGT1). Next, we studied co-exposures of
2-NA and B[a]P. Similar as for 4-ABP also 2-NA enhanced
B[a]P-mediated induction of CYP1A1. Our results demon-
strate that some aromatic amines may enhance the inXuence
of B[a]P on Ah receptor-dependent genes.
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Introduction
Consumption of tobacco products is one of the most domi-
nant contributions in life-style based induction of human
cancer (Wu et al. 2006; Lovreglio et al. 2006). Beside its
role as a cause of lung cancer, smoking is considered as the
most prominent, non-occupational risk factor for the devel-
opment of bladder cancer (IARC 1986, 2004; Kim et al.
2007). Tobacco products are held responsible for »30% of
all cancer deaths in the developed countries (Hecht 2003).
While lung cancer is the most predominant malignant
tumour associated with smoking, several other cancer dis-
eases show a causal relationship with tobacco consumption
(Vineis et al. 2004a). An association between smoking and
bladder cancer has been deduced by case-control and
cohort studies (Brennan et al. 2000, 2001). In particular,
aromatic amines have been in the focus as the putative
causer of this type of neoplasia (Vineis et al. 2004b). Ciga-
rette smoke consists of 4,800 identiWed compounds (Green
and Rodgman 1996), including more than 70 chemicals
with proven, probable or possible carcinogenic eVects in
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about interactions of these substances.
To elucidate the molecular mechanisms of tobacco
smoke-induced bladder cancer in a model system with a
high physiological relevance and with an almost unlimited
access to the biological materials, we utilised the well-
established porcine based primary cell culture system for
our studies (PUBEC). This represents an in vitro system of
epithelial bladder cells that maintains in vivo-like meta-
bolic competence even after long-time cultivation (Guhe
et al. 1996). The cells have no speciWc genetic defects, as it
is the case for all immortalised cell lines. The porcine blad-
der epithelium closely matches the human organ and its
physiological properties (Föllmann et al. 2000a; Guhe et al.
1996; Guhe and Föllmann 1994). It is available as a by-
product of industrial meat production.
Aromatic amines and polycyclic aromatic hydrocarbons
represent two major classes of carcinogens to which blad-
der epithelial cells are exposed. In the present study, we
used 4-ABP and B[a]P as model substances and studied
possible interactions concerning induction of CYP1A1,
COX-2 and UGT1. We report that 4-ABP that alone did not
inXuence levels of enzyme expression clearly enhanced the
enzyme inducing capacity of B[a]P.
Materials and methods
Materials
F-12 (Ham) Nutrient Mixture with GlutaMAX™, penicil-
lin/streptomycin, amphotericin B, transferrin (bovine,
holo), phosphate buVered saline (PBS), trypsin/EDTA, and
non-essential amino acids, Superscript™ II Reverse Trans-
criptase, and Trizol® reagent were purchased from Invitro-
gen (Karlsruhe, Germany). Insulin (bovine, Zn salt)
was obtained from Biochrom KG (Berlin, Germany);
d(+)glucose monohydrate was delivered by Merck (Darmstadt,
Germany). Hydrocortisone, benzo[a]pyrene, 4-aminobi-
phenyl, 2-naphthylamine, non-labelled monoclonal mouse
anti--actin antibody (clone AC-15, IgG1), biotinylated
goat anti-mouse IgG antibody, peroxidase-labelled goat
anti-mouse antibody, and streptavidin–peroxidase (from
Streptomyces avidinii) were from Sigma-Aldrich (Taufkir-
chen, Germany). Long™ epidermal growth factor (EGF,
media grade) was obtained from IBT GmbH (Reutlingen,
Germany). Collagen R was from Serva (Heidelberg,
Germany). Protease inhibitor “complete” tablets were from
Roche (Mannheim, Germany). ECL™ detection reagent
and HyperWlm™ ECL™ were obtained from GE Health-
care Life Sciences (Munich, Germany). Monoclonal mouse
anti-CYP1A1 IgG1 (MAb1A3-03) was purchased from
CYP2000 (Bochum, Germany).
Cell isolation and cell culture
Porcine urinary bladder epithelial cells (PUBEC) were iso-
lated from urine-Wlled bladders of freshly slaughtered bar-
rows of regional provenance (mongrels from German land
pig, German or Belgian noble pig, Piétrain and Duroc). The
cells were cultured under serum-free conditions according
to Guhe and Föllmann (1994), with minor modiWcations as
described earlier (Wolf et al. 2005; Plöttner et al. 2008a).
Urinary bladders were obtained from slaughtered pigs
immediately after opening of the abdominal wall about 15–
20 min after slaughter at the local slaughterhouse of Lünen,
Germany. The organs were transferred to the laboratory in
ice-cold phosphate buVered saline (PBS) supplemented
with 100 g/ml streptomycin, 100 U/ml penicillin, and
2.5 g/ml amphotericin. Under sterile conditions, the blad-
ders were opened and the epithelial mucosa of each bladder
was carefully scraped from the underlying muscle layer
with a sterile glass slide and transferred into PBS. Isolated
cells were centrifuged at 50£g for 5 min. The supernatant
was discarded, and the cell pellet was resuspended in PBS
and centrifuged again. Overall, cells were washed at least
three times to remove cell debris. After the last washing
step, the resulting cell pellet was resuspended with culture
medium. For cell culture, the pellets of Wve bladders were
pooled, and the cell number was determined. Viability was
assessed by trypan blue exclusion (900 l 0.1% trypan
blue + 100 l cell suspension). F-12 (Ham) “Nutrient Mix-
ture” with GlutaMAX™ supplemented with 100 U/ml pen-
icillin, 100 g/ml streptomycin, 1.25 g/ml amphotericin B,
5 g/ml bovine transferrin, 0.1 mM non-essential amino
acids, 10 g/ml insulin, 2.7 mg/ml glucose, 1 g/ml hydro-
cortisone, and 20 ng/ml Long™ EGF was used as culture
medium. This medium, with hydrocortisone and low cal-
cium, was chosen to favour the selective growth of the epi-
thelial cells and to avoid an overgrowth of cultured PUBEC
by possible contamination with Wbroblasts. Additionally,
culture Xasks were coated with collagen type I. For incuba-
tion experiments to assess changes in gene and protein
expressions as well as cytotoxicity, on the day of isolation
12 £ 106 PUBEC were suspended in 10 ml serum-free cul-
ture medium and seeded in 75 cm2 culture Xasks (coated
with 200 g collagen). PUBEC were cultured under stan-
dard cell culture conditions in a humidiWed incubator at 5%
CO2 and 37°C atmosphere according to Guhe and Föll-
mann (1994). Medium was changed after 24 h culture to
remove non-attached and dead cells. On day 2 after isola-
tion, cells were removed from the substrate by 5–8 min
treatment with 0.25% trypsin/1 mM EDTA. The reaction
was stopped by adding equal volumes of culture medium
with 40% (v/v) fetal calf serum (Wnal concentration 20%).
After centrifugation (200£g, 5 min) the supernatant was
discarded and the cell pellet was resuspended in fresh123
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pension cell aggregates were allowed to sediment to the
bottom of the centrifugation tube for a few minutes. The
supernatant with single cells was then transferred into a
new tube and cells were counted before seeding in deWned
densities into new cell culture dishes (2 £ 106 cells in 5 ml
in 25 cm2 Xasks and 20,000 cells per 200 l per well in 96-
well microtiter plates). For the micronucleus test, 106
freshly isolated cells were seeded into 25 cm² Xasks. Cul-
ture medium was changed on day 1 after isolation, and cells
were not passaged as for the other experiments.
Cytotoxicity assay
Cytotoxicity was assessed by means of neutral red (NR)
uptake measurement. PUBEC were seeded in 96-well
microtiter plates in serum-free medium, and evaluated as
described previously (Föllmann et al. 2000b, 2007; Wolf
et al. 2005). In brief, 20,000 PUBEC in 200 l culture
medium were seeded per well in 96-well culture plates.
After 24 h culture the medium was withdrawn and PUBEC
were incubated for 24 h with diVerent concentrations of the
test substances in serum-free culture medium. Afterwards
the incubation medium was withdrawn and substituted by
culture medium with neutral red (0.05 mg/ml), which was
pre-incubated at 5% CO2 and 37°C for 17 h. After another
incubation period of 3 h the medium was withdrawn, and
the cells were washed Wve times with PBS and Wxed with
0.2 ml Wxative (glacial acetic acid/water/ethanol, 1:49:50)
per well which brings the dye NR into solution upon
20 min of shaking (600 rpm) on a plate shaker (MTS2,
IKA® Labortechnik, Staufen, Germany). Then extinction of
NR was measured with a plate photometer (SpectraFluor
Plus microplate reader, Tecan, Crailsheim, Germany) at
540 nm. NR uptake was expressed in percent of that of a
solvent control (DMSO).
In vitro micronucleus assay
The micronucleus assay with PUBEC was conducted
according to Bonacker et al. (2004), based on the method of
Matsuoka et al. (1992), with some adaptations for PUBEC.
1 £ 106 cells were seeded per 25 cm2 Xask (each Xask
coated with 100 g collagen) in F12 (Ham) medium with
supplements (see above). On the next day, the culture
medium was changed to remove non-attached cells. After 2
days in culture the medium was removed and replaced by
fresh culture medium supplemented with the test sub-
stances (dissolved in DMSO), which were added to the cell
cultures in volumes equivalent to 1% of the volume of the
culture medium (Wnal DMSO concentration 0.2%). After an
incubation period of about 1.5 cell cycles (30 h for PUBEC,
to allow expression of micronuclei adjusted to the popula-
tion doubling time of the cells), the medium was removed,
and cells were detached by disaggregation with trypsin/
EDTA (0.05% trypsin in PBS with 0.02% ethylenediamine-
tetraacetic acid). Cells were then subjected to hypotonic
conditions with 0.4% KCl. After centrifugation (130£g,
10 min) the cell pellets were re-suspended in 5 ml ice-cold
methanol/acetic acid (3:1) as Wxative for 15 min at ¡20°C.
This Wxation step was performed three times. After the last
centrifugation, the supernatant was withdrawn, and the cell
pellet was resuspended in 0.5 ml fresh Wxative. Some drops
of the suspension were transferred onto glass slides, and
cells were Wxed by heat treatment. The slides were stained
with acridine orange solution (0.05 mg/ml) and were exam-
ined using a DM LB Xuorescence microscope (Leica, Ger-
many, excitation Wlter 440–490 nm, barrier Wlter I3, 400£
magniWcation, 50 W mercury lamp). For each concentra-
tion, the number of micronucleated cells out of at least
2,000 cells with well preserved cytoplasm was analysed for
micronuclei (MN). The scoring for micronuclei followed
published criteria (Countryman and Heddle 1976; Fenech
1993): Only cells with intact cytoplasm, where the micro-
nucleus size was maximally one-third of the main nucleus
and showed a similar colour and shape, were counted.
Micronucleus-like structures attached the main nucleus of
the cell were not scored. Mean values for treated cell cul-
tures were compared with the respective solvent controls.
The experiment was repeated at least three times.
Real-time reverse transcription PCR (RT-RT-PCR)
Total RNA was prepared from untreated PUBEC and
PUBEC treated with 4-ABP, B[a]P or binary mixtures of
both chemicals with Trizol® reagent (Invitrogen, Karlsruhe,
Germany) following the manufacturer’s instructions and
subjected to DNAse treatment (DNAfree™, Ambion, Aus-
tin, USA). Real-time RT-PCR with on-line detection of
Xuorescence was performed with a Lightcycler 3 instrument
(Roche, Mannheim, Germany). QuantiWcation of CYP1A1,
UGT1 and COX-2 was carried out by one-step RT-PCR as
previously described in detail (Wolf et al. 2005). Three hun-
dred nanograms of total RNA and 6 nmol of gene speciWc
primers were used in a 20 l reaction (DNA Master Sybr-
Green I Mix, Roche) in glass vials (Roche, Mannheim,
Germany). A two-step RT-PCR protocol was adapted for
quantiWcation of CYP1B1 and CYP4B1 and DNA repair
genes: 5 g of total RNA was transcribed to cDNA with
Superscript™ II Reverse Transcriptase (Invitrogen) in a 50-
l reaction. Real-time PCR was carried out with 1 l of the
cDNA solution and 6 nmol of gene speciWc primers accord-
ing to the manufacturer’s instructions (LightCycler FastStart
DNA MasterPlus SYBR Green I, Roche, Mannheim, Ger-
many). Prior to gene quantiWcation primer speciWcity was
veriWed for all genes by cloning and sequencing. A melting123
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after each run. Relative quantiWcation of gene expression
changes was calculated based on the 2¡CP method (Livak
and Schmittgen 2001).
Western blot analysis for CYP1A1
Western Blot analysis was carried out as described previ-
ously (Plöttner et al. 2008b). 2.5 £ 106 cells in 25 cm2 Xasks
were incubated for 24 h with diVerent concentrations of 4-
ABP or 2-NA or co-incubated with 4-ABP or 2-NA and
1 M B[a]P. Afterwards, the incubation medium was with-
drawn and PUBEC were washed twice with PBS. Then cells
were detached from the substrate by treatment with trypsin/
EDTA and centrifuged for 10 min (200£g). The supernatant
was withdrawn and the pellet was frozen in liquid nitrogen
and stored at ¡80°C. For preparation of cell homogenates,
the cell pellets were thawed slowly on ice and resuspended
in 100 l ice-cold homogenization buVer [0.1 M tris-
(hydroxymethyl)-aminomethane, 0.1 M KCl, 1 mM EDTA.
The pH was adjusted to 7.4 with HCl. To inhibit protease
activity, directly before use 23 M 3,5-di-tert-butyl-4-
hydroxybenzyl alcohol and one tablet “complete” protease
inhibitor (Roche, Mannheim, Germany) were added to
50 ml buVer]. The cells were homogenised for 1 min by a
motor-driven pellet pestle (Sigma, Taufkirchen, Germany).
Further homogenisation of the cells was done on ice with an
ultrasonic disintegrator (Sonoplus HD 200, Bandelin Elec-
tronic, Berlin, Germany) at maximum amplitude of 40% in 5
intervals of soniWcation (10 s) and cooling on ice (30 s).
Then, protein content of the cell homogenates was deter-
mined and 2 g of the cell homogenates were applied to
SDS PAGE followed by transfer to a Protran® nitrocellulose
membrane (Whatman Schleicher & Schuell BioScience,
Dassel, Germany). CYP1A1 was detected by the speciWc
monoclonal antibody MAb1A3-03 (mouse IgG1, mini-
PERMTM supernatant) diluted 1:300 in PBS, in combination
with a biotinylated second antibody (goat anti-mouse IgG,
diluted 1:1,000 in PBS + 0.1% Tween® 20) and 2 g/ml
streptavidin-peroxidase conjugate (Sigma, Taufkirchen,
Germany). For visualisation of the reaction, ECL™ detec-
tion reagent and HyperWlm™ ECL™ were applied (GE
Healthcare Life Sciences, Munich, Germany). Quantitation
was achieved with CCD camera digitalised pictures of the
stained immunoblots utilising the image analysis software
WinCam 2.1 (Cybertech, Berlin, Germany). As reference
standard for CYP1A1 detection, liver microsomes from 3-
methylcholanthrene treated rats (Roos 2002) were utilised.
The density values were related to the density of the West-
ern Blot standard and calculated as relative induction per
microgram cell lysate divided by the intensity of 1 g West-
ern Blot standard. For loading control, immunoblots were
stained according to Liao et al. (2000) with monoclonal anti-
-actin antibody (clone AC-15, IgG1, Sigma, Taufkirchen,
Germany) diluted 1:1,000 in PBS in combination with a per-
oxidase-labelled goat anti-mouse antibody.
Statistical analysis
Increased induction of micronuclei in PUBEC by increased
4-ABP concentrations without and in combination with
1 M B[a]P was investigated using a quasi-binomial model
with the log link function accounting for overdispersion
and variation between PUBEC (Paul and Saha 2007). Wil-
liams-type contrasts (Williams 1971) were used to detect a
possible concentrations-related trend supposing a mono-
tone trend for increasing 4-ABP concentrations, 1 M
B[a]P without 4-ABP, and combinations of 1 M B[a]P
and increasing 4-ABP concentrations (Hothorn et al. 2008;
Hothorn and Gerhard 2008). Adjusted p-values were calcu-
lated using the R software packages MASS (Venables and
Ripley 2002) and multcomp (Hothorn et al. 2008). After
checking the data for unequal variances using the Fligner-
Killeen test (Conover et al. 1981) general diVerences
between single and combined concentrations of 4-ABP and
B[a]P or 2-NA and B[a]P, respectively, with respect to the
induction of CYP1A1, UGT1 and COX-2 were determined
using exact two-sided Kruskal–Wallis tests (Hollander and
Wolfe 1999) as sample sizes were small and variances did
not show substantial diVerences. Pair wise exact Wilcoxon
rank sum tests (Hollander and Wolfe 1999) were conducted
to determine possible increases of induction by combina-
tions of B[a]P and 4-ABP using the R software package
exact RankTests. One-sided tests were used to test for an
increase due to single concentrations, two-sided tests were
applied in case of combined high concentrations as down-
turn eVects are likely to occur here. In particular, we used
two-tailed tests for comparisons of B[a]P combinations
with 10 and 50 M 4-ABP or 10 M 2-NA, respectively.
The statistical analysis was performed using the software R
2.7.1 (R Development Core Team 2008).
Results
In order to study, whether 4-ABP inXuences the enzyme
inducing eVect of B[a]P we used the following experimen-
tal setup: cultured primary porcine urinary bladder epithe-
lial cells (PUBEC) were incubated with 1, 10 and 50 M
4-ABP alone as well as in combination with 1 M B[a]P
(Fig. 1). 4-ABP alone (1, 10 and 50 M) did not induce
CYP1A1 expression (Fig. 1a). As known from previous
studies (Wolf et al. 2005; Plöttner et al. 2008a) 1 M B[a]P
caused a clear induction of CYP1A1 mRNA expression.
Interestingly, 4-ABP caused a further increase of B[a]P-
induced enzyme induction (Fig. 1a).123
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lysed induction of UGT1 (Fig. 1b) and COX-2 (Fig. 1c).
Although 4-ABP alone did not induce transcript levels, it
clearly enhanced the eVect of B[a]P. To conWrm the result
on the protein level, we performed Western blot analysis of
CYP1A1, using a similar experimental setup (Fig. 2).
Again, 4-ABP alone did not increase CYP1A1 levels but
clearly enhanced CYP1A1 induction by 1 M B[a]P
(Fig. 2a, b).
Fig. 1 Relative transcript levels of CYP1A1 (a), of UDP glucurono-
syltransferase 1 (UGT1) (b) and of cyclooxygenase 2 (COX-2) (c) in
PUBEC treated with 4-ABP alone (left columns), 1 M B[a]P (dark
grey column) and with 4-ABP in combination with 1 M B[a]P (black
columns). PUBEC were incubated for 24 h with the indicated concen-
trations of the test substances and with the solvent. Relative quantiWca-
tion of gene expression changes was calculated based on the 2¡CP
method (Livak and Schmittgen 2001). n = 3, * signiWcant P · 0.05
(Wilcoxon test, one-sided for 1 M B[a]P + 0, 1 and 3 M 4-ABP,
two-sided for 1 M B[a]P + 10 and 50 M 4-ABP, control = 1 M
B[a]P + 0 M 4-ABP)
Fig. 2 a Representative immunoblot of CYP1A1 protein induction in
PUBEC after treatment with 4-aminobiphenyl (4-ABP), B[a]P and bi-
nary mixtures of 4-ABP and B[a]P determined with Western Blot anal-
ysis (2 g protein per lane). b Relative level of CYP1A1 induction in
PUBEC after 24 h treatment with the solvent (0.2% DMSO, left lane),
with 4-aminobiphenyl (4-ABP), B[a]P and binary mixtures of 4-ABP
and B[a]P. Western Blot signals were normalised by controls from liv-
er microsomes of 3-methylcholanthrene treated rats and induction is
shown as relative induction compared to the microsomal standard (see
“Materials and methods”). * SigniWcant P · 0.05 (Wilcoxon test, one-
sided for 1 M B[a]P + 0, 1 and 3 M 4-ABP, two-sided for 1 M
B[a]P + 10 and 50 M 4-ABP, control = 1 M B[a]P + 0 M 4-ABP),
n = 4; c Relative level of CYP1A1 induction in PUBEC after 24 h
treatment with the solvent (0.2% DMSO, left lane), with 2-naphthyl-
amine (2-NA), B[a]P and binary mixtures of 2-NA and B[a]P. Western
Blot signals were normalised by controls from liver microsomes of
3-methylcholanthrene treated rats and induction is shown as relative
induction compared to the microsomal standard (see “Materials and
methods”), n = 2123
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only 4-ABP enhances enzyme induction capacity of B[a]P
or whether this eVect can also be observed for other
aromatic amines. For this purpose we studied 2-NA using
the same experimental schedule as for 4-ABP (Fig. 2c)
Interestingly, 2-NA enhanced the eVect of B[a]P even more
as 4-ABP. Although 10 M 2-NA alone did not induce
CYP1A1 protein, it caused an almost Wvefold increase of
the eVect of B[a]P (Fig. 2c).
Similar experiments were performed to study whether
4-ABP inXuences B[a]P-induced cytotoxicity (Fig. 3a) as
well as micronuclei (Fig. 3b). However, in contrast to
enzyme induction, 4-ABP did not signiWcantly inXuence
levels of B[a]P-induced cytotoxicity and micronuclei.
Analysis of additional cytochrome P450 isoforms that
are discussed as being relevant in the metabolism of aro-
matic amines in bladder epithelial cells, namely CYP4B1
and CYP1B1 (Imaoka et al. 2000; Carnell et al. 2004), did
not indicate signiWcant expression changes after incubation
with B[a]P, 4-ABP or combinations of both (data not
shown). The same was true for several transcripts related to
DNA repair genes as Xeroderma pigmentosum group A
protein (XPA), DNA helicase XPB (ERCC3), Xeroderma
pigmentosum complementation group C and D (XPC,
XPD), incision speciWc nuclease ERCC1 and X-ray repair
cross-complementing group 1 (XRCC1) (Wood et al. 2001,
Sanyal et al. 2004) (results not shown).
Discussion
In this study, we analysed RNA expression of CYP1A1,
COX-2 and UGT1, which are known to be induced via the
Ah receptor (Ma and Lu 2007; Kawajiri and Fujii-Kuriy-
ama 2007; Yang and Bleich 2004; Degner et al. 2007; Zhou
et al. 2005; Mackenzie et al. 2003). 4-ABP did not induce
CYP1A1, COX-2 or UGT1 up to concentrations of 50 M.
In contrast to 4-ABP, B[a]P is known to be a strong inducer
of CYP1A1 which acts via the Ah receptor (Ma and Lu
2007). In agreement with the latter studies we also
observed an induction of the Ah receptor-dependent genes
CYP1A1, COX-2 and UGT1 by B[a]P. Interestingly,
induction of these genes by B[a]P was enhanced by co-
exposure to 4-ABP. This may be relevant, because bladder
epithelial cells are frequently co-exposed to aromatic
amines and polycyclic aromatic hydrocarbons. Synergistic
eVects may lead to increased levels of enzymes involved in
metabolic activation of bladder carcinogens.
A recent study has shown that bladder epithelial cells of
smokers have indeed higher levels of CYP1A1 than cells of
non-smokers (Dörrenhaus et al. 2007). The mechanism
explaining the interaction between 4-ABP and B[a]P is
unknown. The toxicological relevance of the observed
interaction between the aromatic amines 4-ABP as well as
2-NA with B[a]P still has to be interpreted with caution.
First, we did not observe a synergistic eVect concerning
cytotoxicity and induction of micronuclei. Second, the con-
centrations used in this study (1–50 M for 4-ABP and
1 M for B[a]P, are assumedly much higher than in the
bladder in vivo, although these concentrations have not
been analysed up to now. In such studies DNA adducts of,
e.g., 4-ABP were determined in bladder tissue (Kadlubar
and Badawi 1995; Vineis et al. 1996).
In conclusion, we have shown that aromatic amines may
enhance the induction of Ah receptor-dependent genes by
B[a]P. Whether this mechanism contributes to bladder car-
cinogenesis still has to be evaluated.
Fig. 3 a Cytotoxicity of 4-ABP alone (circles) and in combination
with 1 M B[a]P (triangles) in PUBEC determined with the neutral red
uptake assay. PUBEC were treated for 24 h with the stated concentra-
tions of the test substances. Neutral red uptake is expressed as percent
compared to the solvent control (0.2% DMSO) which is deWned as
100% uptake. b Induction of micronuclei in PUBEC by 4-ABP (light
grey columns), 1 M B[a]P (dark grey column) and 4-ABP in combi-
nation with 1 M B[a]P (black columns). The white column represents
the solvent control (0.2% DMSO). PUBEC were treated for 30 h with
the stated concentrations of the test substances and with the solvent
control. Each column represents data from 4 independent PUBEC cul-
tures, n = 4123
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